Search - tctmd.com

Displaying 41 - 56 of 56

Sort: Relevancy | Date

News Conference News ISET 2019

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

Caitlin E. Cox

February 08, 2019

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Caitlin E. Cox

January 10, 2019

News Features

Top News in Endovascular Therapy: 2018

L.A. McKeown

December 28, 2018

News Daily News

NOACs Significantly Curb Risk of VTE in Cancer Patients

L.A. McKeown

December 06, 2018

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

L.A. McKeown

November 02, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

News Conference News ESC 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

Todd Neale

August 26, 2018

News Daily News

No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT

Michael O'Riordan

July 23, 2018

News Features

Coalition of the Willing: PERTs Aim to Disentangle ‘Gordian Knot’ of Acute Pulmonary Embolism

Todd Neale

January 02, 2017

News Daily News

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

Caitlin E. Cox

November 17, 2016

News Daily News

Catheter-Directed Thrombolysis for DVT Increases Bleeding Compared With Standard Anticoagulation

L.A. McKeown

July 24, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Endovascular Therapy for DVT Appears Safe, Effective in Registries

January 22, 2013

Presentation TCT 2012

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

Presenter: Jeffrey Kuvin

October 23, 2012

News Daily News

Single-Center Studies Build Case for Venous Angioplasty in Multiple Sclerosis

Caitlin E. Cox

April 05, 2012

News Daily News

Study Refutes Venous Hypothesis in Multiple Sclerosis, Weakening Argument for Stenting

L.A. McKeown

March 06, 2012

Advertisement

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Top News in Endovascular Therapy: 2018

NOACs Significantly Curb Risk of VTE in Cancer Patients

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

TCTMD’s Top 10 Most Popular Stories for August 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT

Coalition of the Willing: PERTs Aim to Disentangle ‘Gordian Knot’ of Acute Pulmonary Embolism

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

Catheter-Directed Thrombolysis for DVT Increases Bleeding Compared With Standard Anticoagulation

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Endovascular Therapy for DVT Appears Safe, Effective in Registries

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

Single-Center Studies Build Case for Venous Angioplasty in Multiple Sclerosis

Study Refutes Venous Hypothesis in Multiple Sclerosis, Weakening Argument for Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content